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ER stress responseGlucose-regulated protein 94 is the HSP90-like protein in the lumen of the endoplasmic reticulum and therefore
it chaperones secreted and membrane proteins. It has essential functions in development and physiology of
multicellular organisms, at least in part because of this unique clientele. GRP94 shares many biochemical fea-
tures with other HSP90 proteins, in particular its domain structure and ATPase activity, but also displays distinct
activities, such as calcium binding, necessitated by the conditions in the endoplasmic reticulum. GRP94's mode
of action varies from the general HSP90 theme in the conformational changes induced by nucleotide binding,
and in its interactions with co-chaperones, which are very different from known cytosolic co-chaperones.
GRP94 is more selective than many of the ER chaperones and the basis for this selectivity remains obscure. Re-
cent development of molecular tools and functional assays has expanded the spectrum of clients that rely on
GRP94 activity, but it is still not clear how the chaperone binds them, or what aspect of folding it impacts.
These mechanistic questions and the regulation of GRP94 activity by other proteins and by post-translational
modiﬁcation differences pose new questions and present future research avenues. This article is part of a Special
Issue entitled: Heat Shock Protein 90 (HSP90).
© 2011 Elsevier B.V. All rights reserved.1. Protein folding in the endoplasmic reticulum vs. the cytosol
While most of our knowledge about the HSP90 family of stress pro-
teins is derived from studying the cytosolic HSP90s in unicellular and
multicellular organisms, an important feature of this family is that it
also has representatives in two organellar compartments, the endoplas-
mic reticulum (ER) and the mitochondrion. The HSP90 family member
that resides in the ER is glucose-regulated protein 94 (GRP94), encoded
by the HSP90B1 gene. It is also commonly known as gp96 or endoplas-
min. The various family members are involved in different biological
processes and distinct protein–protein interactions and therefore com-
parisons between them necessarily informs about the unique as well as
the common activities of HSP90 proteins. Here we review the current
knowledge about the functions, mode of action and regulation of
GRP94, highlighting the aspects that are common to HSP90s and those
unique to the ER member of the family.
Since the molecular environment in the ER is rather different from
that of the cytosol (Table 1), and since the ER is the compartment
where membrane and secreted proteins fold and assemble, GRP94
had to evolve to deal with a distinct clientele than HSP90 under differ-
ent conditions. Proteins that fold in the ER tend to have distinct folds,
such as the immunoglobulin domain fold, which is found in a largehock Protein 90 (HSP90).
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l rights reserved.fraction of secretory proteins but not in cytosolic proteins. Many of
the clients of GRP94 have one or more such domains. More than 97%
of all secretory and membrane proteins contain disulﬁde bonds and
are dependent on proper oxidative folding to attain their biological
function. The cysteines in these proteins tend to oxidize because the
lumen of the ER is 30-fold more oxidizing than the cytosol [1] and
there is a sophisticated protein-based mechanism that extracts elec-
trons from, and oxidizes cysteines in proteins that fold in the ER via con-
certed action of one of the many protein disulﬁde isomerases in the ER
(reviewed in Refs. [2,3]). Although GRP94 itself is not an oxidoreduc-
tase, all its known bona ﬁde substrates are disulﬁde-bonded proteins.
A post-translational modiﬁcation that characterizes the vast majori-
ty of secretory andmembrane proteins is Asn-linked glycosylation. This
modiﬁcation introduces important constraints on folding in the ER
lumen, with chaperones and enzymes that interact directly with the
carbohydrates and thereby affect GRP94 action, at least indirectly. Fur-
thermore, the status of glycosylation is an important parameter that is
monitored by the cell to gauge the quality of protein folding, and is
used to determine which proteins should be targeted for degradation.
The disposal relies of translocation of defective proteins to the cytosol
for degradation by the proteasome, and therefore misfolded proteins
in the lumen of the ER require triage, in which GRP94 participates. It is
remarkable that many protein folding and other enzymatic reactions
that take place in the ER require ATP, yet there is no local production
of ATP in the lumen. The ER, unlike the cytosol, must rely completely
on import and exchange of nucleotides from and to the cytosol
Table 1
Protein folding conditions in the ER vs. the cytosol.
Parameter ER Cytosol
Redox state Oxidizing Reducing




Energy generating system No Yes
Glycosylation machinery Yes No
Proteolytic machinery No Many
HSP70 chaperones BiP/GRP78, GRP170 HSP70 ,HSC70
HSP90 chaperones GRP94 HSP90




Comparison of conditions that affect protein folding and disposal of misfolded proteins
(parameter) and the response to changes in these conditions between the ER and the cytosol.
Fig. 1. Phylogenetic analysis of some HSP90 family members. The analysis is based on se-
quence comparisons of human cytosolic HSP90α (AAI21063.1) and HSP90β
(NP_031381.2), human GRP94 (AAH66656.1), Arabidopsis thaliana GRP94 (NP_974606.1)
and TRAP-1 (NP_057376.2), yeast HSP82 (P02829.1) and HSC82 (AAA02813.1), E. coli
HtpG (AP_001122.1) and Leishmania infantum GRP94 (ADP89477.1) and Trypanosoma
cruzi GRP94 by the algorithm MUSCLE, using the web site T-Coffee. The GRP94s are
highlighted in red. Numbers at the nodes are bootstrapping values to validate the analysis,
performed using PhyML3.0. The X axis indicates the expected amount of sequence change,
which is a combination of time and inherent mutation rate. Inherent mutation rate can be
different for each genome, complicating the comparisons. Bar, 0.1 units.
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proteins, which use ATP binding and hydrolysis in their action cycle.
Another important constraint on GRP94 activity is calcium. The ER
lumen is a major calcium storage compartment, where Ca++ is stored
by binding to multiple proteins, and GRP94 is one of the major Ca++
binding proteins [4]. In addition, GRP94 has to contend during its ac-
tion cycle with ﬂuctuations in free Ca++ in the lumen, as protein-
bound Ca++ is released and leaks through the ER membrane channels
to the cytosol, based on the physiological demands of the cell. Since all
the above parameters deﬁne quite a different homeostatic environ-
ment in the ER than in the cytosol, it also follows that changes in
these parameters pose distinct stresses to these two compartments.
Alteration of either ER Ca++ balance, the redox status or the glycosyl-
ation machinery each initiates a distinct signal that is processed by
stress signal transducers located in the ER membrane, triggering a
complicated signaling system that together is known as the ER stress
response or the unfolded protein response (UPR). The purpose of this
system, much like the corresponding stress signaling in the cytosol is
to either restore homeostasis or target the cell to apoptosis. However,
the two stress responses are initiated by distinct stress signals, use
distinct signal transducers, rely on distinct transcription factors and
target distinct gene sets. GRP94 and other ER chaperones are among
the main target of the ER stress response and in addition play a role
in mediating the response.
GRP94 has long been an enigma. While it was recognized long ago
as a major indication of ER stress [5], a major calcium binding [6] and
a peptide-binding protein [7], it was not clear how it recognizes its
substrate proteins, whether or how it uses ATP hydrolysis in its action
cycle, whether it uses co-chaperones to regulate its activities, and
perhaps most critically - how important it is for cellular functions.
In the following sections we describe the considerable recent pro-
gress that provides answers to some of these questions.2. Evolutionary relation
GRP94 is present as a single gene in all metazoa, whether from the
animal or plant kingdom. Even though GRP94 is not found in bacteria,
archea, yeast, most fungi and other unicellular organisms, it is present
in the parasites Leishmania and Trypanosoma. Phylogenetic analysis
indicates that organellar and cytosolic HSP90 family members
evolved separately from a common ancestor, distinct from the ances-
tor of HtpG and TRAP (Fig. 1 and Refs. [8,9]). Remarkably, the GRP94s
in the unicellular parasitic organisms evolved separately from the
plant or animal kingdom GRP94 (Fig. 1), perhaps fulﬁlling different
functions. Apparently the distinction among the GRP94s occurred
after the evolution of eukaryotic compartments. If so, unicellular eu-
karyotes like most yeasts, that have ER but do not have GRP94 ortho-
logues, may have lost them during evolution. The absence of GRP94
from Saccharomyces deprived researchers of a powerful geneticapproach to understand GRP94's activity, no doubt diminishing the
ability to place this chaperone in the context of ER functions.
3. GRP94 serves an essential function
In metazoans GRP94 is an essential gene. RNAi knockdown
GRP94 in Dictyostelium leads to delayed development and small
fruiting bodies [10]. Loss of function of Arabidopsis GRP94 (the
Shepherd mutant) causes defects in meristem development through
loss of interaction with CLAVATA proteins [11]. GRP94 is also essen-
tial in C. elegans, since RNAi knockdown each causes a development
arrest at an early larval stage, without maturation of adult worms
(WormBase, release WS198). In Drosophila, the orthologous protein
gp93 is also needed for larval development and mutant larvae have
pronounced defects in their midgut epithelium [12]. Finally, mouse
development is arrested without GRP94 in gestational day 7, before
gastrulation and formation of mesodermal tissues [13]. Thus, in
each organism, GRP94 is required during a speciﬁc, early develop-
mental stage. The genetic requirement for GRP94 does not coincide
with the onset of its expression (GRP94 is made throughout em-
bryogenesis, including in the zygote) and there is likely maternal
inheritance of GRP94, which sustains its functions in early embryos.
This is supported by the data on zygote-speciﬁc knockout of GRP94,
which reveals a requirement for it during the ﬁrst mitosis [14].
Thus, it is likely that GRP94's essential function is exposed when
it is needed for particular protein–protein interactions. The required
interactions likely differ from organism to organism, as the develop-
mental schemes vary considerably. Nonetheless, whatever the mo-
lecular functions, they are essential primarily for metazoa, because
GRP94 is not expressed in most unicellular organisms, and it is
also not essential for growth of individual mammalian cells in cul-
ture. GRP94-deﬁcient cells can grow normally [15], albeit more
slowly [16], do not have global deﬁciency in surface receptors ex-
pression [15], and are still capable of differentiation [13]. Therefore,
GRP94 is not needed to support trafﬁc of secreted or plasma mem-
brane proteins in general, but has more selective effects. This is sur-
prising for a protein that is expressed in virtually every cell
(including the zygote) and is among the most abundant ER constit-
uents [17].
The functions of GRP94 in unicellular organisms may be differ-
ent than in metazoa. Leishmania GRP94 (LPG3) is not needed for
viability, but rather is involved in virulence of the parasite [18].
A point mutant in LPG3 affects the addition of galactosyl residues
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protein of Leishmania and also has other defects in conjugation
of glycans [18].
4. Subcellular localization
High-resolution microscopy techniques show that GRP94 is con-
ﬁned to the lumen of the ER, or the related sarcoplasmic reticulum
of muscle cells [19]. GRP94 is targeted to the ER by its 21 amino
acid N-terminal signal sequence, which is cleaved upon entry to the
lumen, exposing the DDEV terminus of the mature protein (Fig. 2).
GRP94 maintains its residence in the ER by using its C-terminal se-
quence KDEL, which serves as an ER retrieval signal for the KDEL re-
ceptor [20]. The KDEL-mediated retention system is important for
the localization of GRP94, because a human variant lacking this signal
is secreted rather efﬁciently, leading to lower steady state levels of
GRP94 in the cell (Marzec, Eletto and Argon, unpublished). Nonethe-
less, the ER retention is not absolute and GRP94 has been reported to
escape retention in several cell types. A remarkable exception to the
ER localization of GRP94 is its association with the bile salt-
dependent lipase (BSDL), also known as cholesterol esterase. This en-
zyme is secreted by pancreatic acinar cells in a complex with GRP94
and the two remain associated in the pancreatic juice until it arrives
at the intestinal lumen [21]. There, the complex is somehow internal-
ized by enterocytes and both molecules are found in endosomes.
BSDL, but not GRP94, is eventually deposited on the basolateral mem-
brane of enterocytes. It is not clear whether GRP94 is needed for BSDL
uptake or whether it simply protects BSDL from degradation in the
duodenal lumen [21,22]. Secretion of GRP94 (and other ER luminal
proteins) by exocrine pancreatic cells [23] and by hepatocytes [24]
has also been reported. In all these cases it would be very interesting
to elucidate the mechanism that overcomes ER retention. Knowledge
of the mechanism also has practical importance, given the potential
power of deploying extracellular GRP94 as a peptide-binding vaccine
(Section 9.4).
A second reported exceptional location is the cell surface. In tumor
cell lines and in the myoblast line C2C12 GRP94 is detectable as a sur-
face protein (e.g. [25,26]), where its peptide-binding ability could af-
fect the interaction of tumor cells with the immune system. The
physiological signiﬁcance of surface GRP94 expression remains
unclear in the absence of an in vivo tumor model. Another interesting
case of surface GRP94 expression is presented by thymocyte develop-
ment. At a speciﬁc, early developmental stage, immature thymocytesFig. 2. Comparison of structural features between GRP94 and HSP90β. Schematic representa
domain (NTD). Beige, charged linker domain. Orange, middle domain (MD). Brown, C-term
indicated for each of the 4 domains. Grey, the signal sequence of GRP94. Yellow and
C-terminal tetrapeptide of GRP94 that serves as the ER retention/retrieval ligand for the KD
for binding of various TPR containing proteins. ATP, the nucleotide-binding site. CHO, the N
linker of GRP94 [92].express 1–5% of their GRP94 and calnexin on the plasma membrane
and as they mature, the ER proteins are again conﬁned to their nor-
mal intracellular location ([27] and Argon, unpublished data). The es-
cape from ER localization is perhaps due to masking of ER retention
by association with other proteins; in the case of calnexin it was at-
tributed to assembly of partial T cell receptor complexes [27] that
perhaps masks ER retention signals. Another possibility is that there
is an alternative membrane-spanning form of GRP94 [28], but this
had not been conﬁrmed by other studies and GRP94 is highly soluble
in the absence of detergents.
A membrane-bound sub-population of GRP94 was proposed to
also account for observed interactions between GRP94 and cytosolic
proteins. For example, such physical association was proposed to reg-
ulate the level of expression of Fanconi Anemia Group C protein [29].
Similarly, the frequent observations of phosphorylation of GRP94 by
the cytosolic enzyme casein kinase II [30,31] could perhaps be due
to a membrane-spanning fraction of GRP94.
Another mechanism that could account for the published associa-
tion with cytosolic proteins is the presence of a distinct cytosolic sub-
population of GRP94. Precedents for such a population are provided
by observations that two other luminal chaperones, calreticulin and
BiP, have minor cytosolic forms. Cytosolic calreticulin could be creat-
ed because of its inherently inefﬁcient signal peptide, which fails to
target a fraction of the molecules into the ER [32]. Cytosolic BiP can
be created by alternative splicing that causes alternative translation
initiation [33]. Yet a third possible mechanism for cytosolic localiza-
tion of luminal proteins is retro-translocation through the ER mem-
brane. There is yet no compelling evidence for the existence of a
cytosolic population of GRP94 molecules, via any of the abovemen-
tioned mechanisms. Such existence would be convincing if the sub-
population of GRP94 would acquire a new property or a new function.
5. Transcriptional regulation
Together with BiP/GRP78, GRP94 is probably best known as the
hallmark of the UPR response. It was originally described as a glucose
responsive protein whose transcription and translation are induced
when the cellular supply of glucose diminishes below physiological
levels [5,34]. When glucose is low within physiological levels,
GRP94 expression is actually downregulated [35]. GRP94 has since
been shown to respond in the same manner to all types of stresses
that affect the ER machinery - perturbations of calcium or redox ho-
meostasis, inhibition of glycosylation, amino acid analogs that likelytion of the domain organization of human GRP94 and human HSP90β. Blue, N-terminal
inal domain (CTD). The similarity between them is indicated by the percent identity
red, unique sequences that distinguish the two members of the family. KDEL, the
EL receptor [20]. MEEVD, the C-terminal peptide of HSP90, which serves as the target
-glycosylation site of GRP94. Ca++, the known calcium binding activity of the charged
Fig. 3. Comparison of the promoter of GRP94 with other ER chaperone genes. A. Sche-
matic representation of the promoter of human GRP94, compared to other ER chaper-
one genes. The ERSEs in each promoter are indicated by boxes and are numbered.
Arrows indicate the orientation of the ERSEs whose function is orientation-
independent. The numbers below the ERSEs deﬁne the bp position relative to the tran-
scription start site (TSS). The dark grey boxes depict perfectly matched ERSEs, and the
light grey boxes - imperfectly homologous ERSE, see below. GRP94 promoter has two
canonical ERSEs, BiP and PDIA6 have one. In contrast, the PDIA1 promoter of a poorly
inducible gene in mammals, has only two mismatched ERSEs. Note: the scheme is
not to scale. B. Sequence comparison of the ERSEs of the indicated genes. The CCACG
3′ motif of ERSE-2 and -4 of the GRP94 promoter have one base mismatch with the
consensus sequence. The PDIA1 ERSE-1 contains two mismatches.
777M. Marzec et al. / Biochimica et Biophysica Acta 1823 (2012) 774–787cause nascent chain misfolding, hypoxia, etc. [36,37]. Unlike HSP90α
and β, GRP94 is not induced by high temperature or other stresses
that are unique to the cytosol [36]. Importantly, GRP94 and BiP are in-
duced also by physiological ER stress, for example during differentia-
tion of cells [38–43]. Consequently, the steady state level of GRP94
expression in liver, a professional secretory tissue, is 5 times higher
than in skeletal muscle or other non-secretory cells (Argon et al.,
unpublished data). The main mechanism controlling the expression
of GRP94 is transcriptional regulation [17,36,37]. Transcription of
GRP94 is usually initiated by activation of the signal transduction
pathways that inform on changes in physiological conditions in the
ER lumen and cause the activation of transcription factors - the Ire-
1/XBP-1 pathway, the PERK/eIF2a pathway and the ATF6 pathway
(reviewed in Ref. [44]).
Sequence analysis shows that the promoter of GRP94 is highly
similar to that of other ER stress inducible promoters characterized
by the presence of a large number of CCAAT-like motifs ﬂanked by
GC-rich regions [45,46]. These signature features were later charac-
terized as ER stress elements (ERSE) which are cis-acting elements
shown to mediate the responses to ER stress [47,48]. ERSEs consist
of an evolutionarily conserved tripartite structure CCAAT(N9)CCACG,
where N9 is a GC-rich linker. The CCAAT motif is bound by the multi-
meric nuclear factor NF-Y, but while this binding is required for GRP
promoter activity, it is not sufﬁcient and speciﬁcity is conferred by
the binding of the UPR transcription factor ATF6 to the 3′ CCACG
motif of ERSEs. The 9 bp linker is also functionally important since
mutations disrupting a GGC triplet in it lead to loss of stress inducibil-
ity [47].
Human GRP94 promoter contains four ERSEs (Fig. 3). Using re-
porter assays, most of the transcriptional activation in response to
tunicamycin was accounted for by ERSE-1 and –3 [47]. This may be
due by the fact that binding of ATF6 is profoundly inhibited by mis-
matches in the CCACG motifs of ERSE-2 and -4 (Fig. 3B).
The GRP94 promoter can be activated not only by ATF6 but also by
another transcription factor that characterizes the UPR, XBP1 [49]. It
is not entirely clear what sequences XBP1 binds in mammalian pro-
moters. The ER stress-responsive element UPRE [50], which contains
the consensus sequence TGACGTGG/A, is the only element responsi-
ble for UPR in yeast, mediated by XBP1. The promoter of GRP94, as
well as of many other ER chaperone genes, does not contain a canon-
ical UPRE. However, XBP1 can also bind the CCACG motif in the ERSE
(Fig. 3), at lower afﬁnity than ATF6, [50].
The functionality of GRP94 promoter has only been tested in re-
sponse to chemical inducers of ER stress and clearly, other elements
that are yet to be discovered, mediate the transcriptional regulation
in other conditions. For example, basal expression of GRP94 and BiP
is dependent upon and regulated by a mitogenic pathway distinct
from the UPR and probably controls the basal expression needed to
assist protein biogenesis in the ER of normal, non-stressed cells [51].
Another example is hypoxia, where GRP94 is the most induced gene
[52]. This response is mediated by hypoxia inducible factor 1 via a
site that is also distinct from ERSE [52].
There is an interesting transcriptional parallelism between the ER
compartment and the cytosol: when HSP90s are inhibited, a signiﬁcant
induction of cytosolic HSP70s, dependent on the transcription factor
HSF1, is observed (reviewed in Ref. [53]). Similarly, in both worms
and cell culture, inhibition or ablation of GRP94 induces the expression
of BiP [54] (Eletto et al., unpublished data). It should be informative to
pursue the physiological signiﬁcance of this transcriptional connection
given that the respective HSP90/HSP70 chaperones do not have the
same interactome, but often work in concerted fashion.
6. Posttranslational modiﬁcations
The function and action cycle of cytosolic HSP90 are regulated bypost-
translational modiﬁcations: it is known to undergo phosphorylation onmultiple tyrosine, serine and threonine residues, as well as acetylation
on lysine residues, and these modiﬁcations provide fast and precise
mechanisms to regulate its conformation, substrate speciﬁcity and ac-
tivation [55,56]. Being in the ER, separated from cytosolic kinases,
phosphatases, acetylases etc., much less is known about the role of
posttranslational modiﬁcations in GRP94 activity.
6.1. Glycosylation
The only certain post-translational modiﬁcation on GRP94 is
the attachment of one N-linked carbohydrate attached to Asn196.
There are 4 other N-linked acceptor sites in the N-terminal domain
(NTD) and the middle domain (MD), but none is apparently used.
Likewise, no O-linked glycosylation of GRP94 has been reported.
The N-linked glycosylation does not have any known impact on the
biological activity of GRP94: even when non-glycosylated, GRP94 as-
sociates with Ig light chain [57] and with α1-antitrypsin (Dersh and
Argon, unpublished).
6.2. Phosphorylation
Ser/Thr phosphorylation of GRP94 has been described for the ﬁrst
time by Cala et al. in cardiac sarcoplasmic reticulum [19] and then by
Trujillo et al. who ascribed the phosphorylation to casein kinase 2
(CK2) [58,59]. Phosphorylated GRP94 and CK2 have also been co-
puriﬁed from Golgi membranes [60–62]. The conceptual problem
with these studies is that CK2 is considered to be a cytoplasmic
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main that would explain its association with ER or Golgi complex
[62]. A distinct modiﬁcation, tyrosine phosphorylation of GRP94 by
the Src kinase Fyn was reported to occur during myogenic differenti-
ation in C2C12 cells [26]. Evidence was provided, by confocal micros-
copy, immuno-electron microscopy and cell fractionation, that Fyn
indeed co-localizes with GRP94 in the ER. As with CK2, there is no
molecular explanation for the localization of a Src kinase in the
lumen of the ER, so it is still unclear what is the physiological signiﬁ-
cance of this Tyr phosphorylation, although it correlates temporally
with myocyte differentiation.
Two groups reported that GRP94 possesses autophosphorylating
activity [30,63], but Reed et al. argued that it was due to insufﬁcient
puriﬁcation of the protein and was not an authentic GRP94 activity
[64].
As discussed in Section 4, an alternative explanation is that
phospho-GRP94 is a sub-population of the protein that is somehow
located in the cytosol, where it could be phosphorylated by soluble ki-
nases. A precedent for this explanation is the cytosolic pool of calreti-
culin (Section 4). On the other hand, unlike calreticulin, GRP94 seems
to be targeted to the lumen rather efﬁciently, is not subject to signif-
icant proteasomal degradation [65] and there is no evidence for alter-
native splicing of exons, all of which argues against the presence of a
signiﬁcant cytosolic population of GRP94.
It is worth noting that other luminal ER proteins were shown to be
phosphorylated. GRP58, GRP75 and BiP are phosphorylated in vivo, on
their luminal domains [66–68] and importantly, BiP phosphorylation
has regulatory function towards its peptide-binding capacity [69].
Nonetheless, those reports are difﬁcult to interpret for the same rea-
sons listed above regarding GRP94.
6.3. Acetylation
HSP90 is known to undergo acetylation [70] and this modiﬁcation
has functional signiﬁcance [71–73]): Acetylation of Lys 294 in the mid-
dle domain regulates HSP90 client binding and association with co-
chaperones [56]. This Lys is conserved in GRP94, and other Ac-Lys
sites are predicted (PHOSIDA - Posttranslational Modiﬁcation Data-
base), but not demonstrated yet. Recently, the ﬁrst acetylation of a lu-
minal ER protein, BiP has been reported [74], and shown to be
involved in its binding to PERK and subsequent regulation of the unfold-
ed protein response [75]. Furthermore, work by Ko et al. described ER
acetyl-CoA:lysine acetyltransferases, ATase1 and ATase2 [76], as well
as a membrane transporter, AT-1, that translocates acetyl-CoA into the
lumen of the ER [77]. Thus, the machinery for acetylation in the ER is
in place and it seems prudent to ask whether acetylation affects
GRP94 activity in analogous fashion to its effect on HSP90.
7. Structural comparison between GRP94 and HSP90
The domain organization of all HSP90 family members is con-
served in GRP94s: an N-terminal domain (NTD) followed by a
charged linker domain, then the middle domain (MD) which is divid-
ed to two sub-domains, and ﬁnally the C-terminal domain (CTD). Two
obvious structural differences are in the N- and C-termini of GRP94
vs. HSP90 (Fig. 2). The ﬁrst ~50 amino acids of mature GRP94 are dis-
tinct from the N terminus of HSP90 in both length and sequence. This
implies that the function/conformational change performed by the
ﬁrst 24 residues of cytosolic HSP90, including participation in the di-
merization of N-terminal domains after ATP binding and lid closure
[78] (see Section 8.2) are likely distinct in GRP94.
7.1. The N-terminal domain
The distinct N-terminal sequences are followed by highly homol-
ogous sequences throughout the NTD. The identity includes all theresidues that contact the nucleotide in the binding pocket and
those that catalyze ATP hydrolysis. The homology between GRP94
and HSP90 is such that compounds that bind competitively to this
site have similar afﬁnity for GRP94 and for HSP90 [79–82]. The
NTD belongs to the Bergerat fold of ATP-binding proteins [83,84]
and has the unusual property for an ATPase of similar afﬁnity for ei-
ther ADP or ATP [82,85]. In addition, the nucleotide-binding site of
GRP94 accommodates geldanamycin, radicicol and their derivatives
[79,82, 85–87], albeit at slightly different docking orientations [88].
So far, all known compounds that bind HSP90 also bind GRP94.
This is an important feature that is often under-emphasized while
interpreting the effects of inhibitors on an HSP90-dependent process.
The one exceptional inhibitor is the adenine analogue NECA, which
binds speciﬁcally to GRP94 and not HSP90s, due to a modiﬁed lid
over the binding site, formed by a 5 amino acids insertion between
helix 4 and 5 that is speciﬁc for the GRP94s [82]. Binding of all the
geldanamycin or radicicol derivatives to GRP94 has been shown to
have important functional consequences. The activity of GRP94 to-
wards clients and its importance during cellular stress are impaired
by either compound [79,89]. This inhibitory activity is mediated by
conversion of the protein to a ‘closed’, more compact conformation
[80,90] (see Section 8 below).
The NTD contains one N-linked glycosylation site at Asn196 (four
other similar sites do not appear to be used normally), but the glyco-
sylation is not essential for the biological activity of GRP94 [57].
7.2. The charged linker domain
The second domain of GRP94 is the charged linker, whose struc-
ture cannot be resolved by crystallography. This domain is essential
for the activity of GRP94, because it mediates conformational changes
that, among other things, are needed for ATP hydrolysis [79,80]. More
recently, similar functional importance for the charged linker domain
of HSP90 has also been determined both in vitro and in vivo, and it af-
fects interaction with co-chaperones and clients [91]. The charged
linker domain is shorter in GRP94s than in HSP90s and is divided
more cleanly to an E/D-rich sequence followed by a poly-K stretch
(Fig. 4). The former sequence contains 1–2 calcium binding sites
whose occupation induces a conformational change that impacts the
NTD [92]. Presumably, the HSP90 linker domain does not share this
Ca++-binding property because its negatively charged residues are
interspersed frequently with lysines, creating sequences that are not
conducive to coordination of metal ions.
The charged linker domain also contains the epitope for an anti-
GRP94 monocloncal antibody which is conformation-sensitive [80],
indicating that this charged domain is important for the activity of
the chaperone. Strands 8 and 9, which ﬂank the charged linker,
form an anti-parallel sheet in at least one crystal form [86], and the
Trp zipper motif WDWE, in strand 9 was proposed as an interface
that communicates with the NTD [93].
7.3. The middle domain
The high sequence and structure similarity with HSP90 continue
throughout much of the MD. Its N-terminal sub-domain forms the
split ATPase structure in both GRP94s and HSP90s; it harbors the
catalytic loop, which interact with the nucleotide-binding site in
the NTD and is needed for ATP hydrolysis [84] (Fig. 2) as well as
a hydrophobic patch, which like in HSP90 is important for domain
interactions. All the functionally important residues in the catalytic
loop, the hydrophobic loop and other elements of the M domain
in HSP90 are remarkably conserved in the ER paralogue. Other
than the residues that interact with the NTD, no functions have
yet been mapped to the MD despite the conservation of other resi-
dues that in cytosolic HSP90s mediate contacts with co-chaperones
[94].
Fig. 4. Comparisons of the linker domains of human HSP90β (hum90β) and GRP94 (hum94). *, identical residues. :, similar residues. Blue, acidic residues. Red, basic residues. Pur-
ple, Asn and Gln. Green, aromatic residues. Orange, aliphatic residues. Brown, Pro. Black, small side chain residues. Strands 8 and 9, which ﬂank much of the charged stretches and
bind the domain to the N-terminal domain are indicated, and the Trp zipper domain interaction motif within strand 9 is underlined. The heavily negative sequence in the middle of
the GRP94 domain is likely to contain a Ca++ binding site [92]. A human GRP94 allele has Pro300Leu substitution (yellow highlight) (http://browser.1000genomes.org/index.html,
rs116891695). This sequence comparison is instructive because a 3D structure for the charged linkers has proven elusive.
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have a ~20 residues insertion rich in charged residues, which is miss-
ing from the other GRP94s and from the HSP90s. Perhaps this sub-
domain mediates divergent functions or protein interactions in the
plant and animal ER.
7.4. The C-terminal domain
The main known molecular function of the C-terminal domain
(CTD) of GRP94 is to provide a homo-dimerization interface. This is
accomplished, as proposed by Nemoto et al., through a pair of inter-
domain interactions between the MD and CTD [95]. The interface in-
cludes four helices - helix 9 from the C-terminus of the MD and
helices 2, 4 and 5 of the CTD [95,96]. The latter two helices correspond
to the hydrophobic segment originally identiﬁed in [97]. This inter-
face is used constitutively, accounting for the primary cellular form
of GRP94 [97]. Detailed examination of the crystal structure reveals
that CTD helix 6 from each GRP94 monomer contacts the loop region
between helix 3 and strand 3 of the opposite CTD, an interaction that
acts as a strap that enforces the dimerization. This is perhaps the rea-
son for the apparent obligatory dimerization of GRP94.
Anovobiocin binding site in theCTDof humanHSP90α,ﬁrst identiﬁed
by Marcu et al. [98,99] and mapped by Matts et al. [100], centers around
the K559KQEEKK564 sequence. In the closed conformation of the CTD,
the most frequently crystallized conformation [86], this site in not acces-
sible, indicating that ligandbinding to this site is coupled to the conforma-
tional equilibrium of the entire protein. Interestingly, this sequence is not
conserved in the GRP94 sequences, and plant GRP94s even have a 4
amino acid deletion in this peptide. Despite such sequence divergence,
the SPC597 sequence which is adjacent to the novobiocin binding site in
the crystal structure [86] and was shown to be part of a conformational
control point of HSP90 that impacts the entire dimer [101], is conserved
in GRP94s. Because the allosteric regulation of the ATPase cycle and
NTD and CTD conformations likely underlie the mode of action of
GRP94s and HSP90s (Section 7), possible differences between these
orthologues should be investigated further.
The protein terminates with a ~55 residue acidic region, which is
longer by about 20 residues than the corresponding CTD of HSP90,
is more continually acidic in GPR94s, lacks the C-terminal RMEEVD
sequence of HSP90 and instead encodes the KDEL terminus that spec-
iﬁes ER retention/retrieval. Consequently, GRP94 lacks the motif
shared between HSP70 and HSP90 that is essential for their activity
[102], because it binds TPR motifs that are present in a number of
co-chaperones [103]. Instead, the KDEL peptide is the binding site
for an intracellular receptor, which shuttles between the Golgi and
the ER and retrieves luminal KDEL proteins that have escaped the ER.
7.5. Where is the client binding site?
The main enigma about GRP94's structure/function relationship is
the identity of the sites for binding other proteins, either clients or co-factors. The ample literature on peptide binding by GRP94 and its use
as a peptide presentation device for T cell responses (for reviews see
[104,105]) apparently focuses on the activity of the peptide-binding
site in the NTD [106]. However, peptide presentation does not seem
to be a major in vivo function of GRP94 [107], and furthermore,
while in many other chaperones their peptide-binding capacity was
a valid surrogate measure of client protein binding activity, the pep-
tide-binding activity of GRP94 appears to be distinct from the
chaperoning activity [108]. Thus there must be an active site(s) else-
where in the protein. GRP94 shares this enigma with HSP90s, whose
mode of binding clients has also not yet been elucidated. The circum-
stantial evidence for all family members suggest that clients bind
somewhere along the MD and CTD [109,110]. While mapping of
such a site in GRP94 is in progress, none has yet been deﬁned.
8. How does GRP94 work?
8.1. Conformational equilibrium
GRP94 had long been thought to function in unique manner when
compared with its cytosolic homologs. Nonetheless, Agard et al. have
shown that it cycles in vitro through an equilibrium of solution con-
formations that is similar to that seen in Hsp90α and Hsc82 [111].
One main population is in an extended, chair-like conformation
with a rotated CTD (relative to the crystal structure). A second,
minor population is in a less extended conformation whose CTD ori-
entation is similar to that in the GRP94 crystal structure. Yet a third,
low level population is even more closed, a conformation represented
by the “twisted V” crystal structures of GRP94 with nucleotides
[82,85,86,112]. The extended conformation could allow for a large
surface of interaction with client proteins and it is also a conformation
that is receptive for nucleotide binding [81]. The addition of nucleo-
tide, and probably of client proteins and co-chaperones, shifts the
preexisting equilibrium toward the more closed states, as opposed
to determine a speciﬁc conformation. The presumption is that
GRP94 functions by a ligand-dependent conversion from an inactive
to an active conformation [113], though which ligand is activating
and what function is activated are questions that are yet to be
resolved.
Though GRP94 exists almost exclusively as a dimer in solution, the
importance of the dimeric nature is not fully understood, because in-
dividual monomers can bind ATP [113] and peptide [80]. It is not yet
known if monomeric GRP94 can be an active ATPase or an active chap-
erone in the cell. Indirect evidence for the importance of the dimeric
structure was provided when native subunit interactions in GRP94
were analyzed using chemical cross-linking and mass spectrometry
sequencing [96]. In addition to the C-terminal dimerization domain,
another intermolecular contact was identiﬁed -between the NTD and
MD of opposing subunits. This N-to-M domain interaction is found
in apo-GRP94 as well as the nucleotide— or geldanamycin-bound
states and presumably reﬂects the more intertwined conformations
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lize the active site of each monomer in HSP90 [114], reinforcing the
importance of the dimeric structure in the biological activity of the
family members.
Since GRP94 is a high-capacity Ca++ binder and the free Ca++
level in the lumen changes over three orders of magnitude, it is sur-
prising that in vitro Ca++ does not affect the global conformational
equilibrium of GRP94 [111] even though a local conformation change
is transmitted from the charged linker domain to the NTD [92]. It is
also notable that no role has yet been assigned to cysteines in the ac-
tivity of GRP94, despite the unique redox state of the ER and the fact
that all GRP94's clients are disulﬁde-bonded proteins.
8.2. Nucleotide binding, hydrolysis and NTD dimerization
While the conformational equilibrium of GRP94 resembles that of
the other family members, GRP94's action cycle is regulated different-
ly from that of HSP90s. One major difference is the response to nucle-
otide binding: GRP94 adopts the twisted V conformation upon
binding either ADP or ATP [86]. The two nucleotides bind to GRP94
with similar afﬁnities and ATP does not become kinetically trapped
upon binding, as happens when it binds to the HSP90 NTD. This dif-
ference is rooted in the effect that binding of either nucleotide exerts
on GRP94's structure: the “lid” over the nucleotide-binding pocket,
formed by helices 1,4,5 and their connecting loops, opens upon nucle-
otide binding, rather than closing and trapping ATP, as in HSP90
[81,85,112].
A second aspect of regulation that distinguishes GRP94 from
HSP90 is the dimerization of NTDs. In HSP90, the changes in the con-
formation of NTD elements during the nucleotide cycle couple the
activity of the chaperone to transient clamp-like dimerization of the
NTDs, primarily via helix N1 [78,94,115,116]. GRP94 also requires
NTD dimerization for nucleotide hydrolysis, because mutants of
GRP94 lacking strand N1, or strand N1 and helix N1, were defective
in ATP hydrolysis, like the corresponding mutants in HSP90 [86]. In
addition, the crystallized isolated NTD in a nucleotide-bound state
has a conformation that leads to N-domain dimerization [86]. How-
ever, in contrast to HSP90, the twisted conformation of GRP94
keeps the structural elements necessary for dimerization of the two
NTDs apart, on opposite sides of the dimer [86], so to achieve a cat-
alytically active conformation, GRP94 must rotate the two NTDs
about the N-M and M-C junctions. Since the isolated NTDs do not
change their conformation in response to ATP or ADP, perhaps the
impetus for NTD dimerization in GRP94 is provided by binding of cli-
ents or co-chaperones, linking protein–protein interactions to ATP
hydrolysis.
It is still not known how the opening of the lid in GRP94 and the
rotations of the NTD regulate the action cycle of GRP94 mechanisti-
cally. They may be related to the ability of each monomer of GRP94
to cycle between the open and closed conformations independently
of each other [113], which would provide a mechanism for sensing
nucleotides’ level in the lumen.
8.3. ATPase activity
The hydrolytic activity of GRP94 had been controversial for years,
but is now known to be as efﬁcient as other HSP90s [81,86]. In fact,
there is a larger difference in the Km and Kcat of the respective
ATPase activities between yeast and human HSP90 than between
yeast HSP90 and mammalian GRP94 [81,86]. The disparity in the in-
herent catalytic rates between the two paralogues is due to sequence
differences in the NTDs, as shown by the kinetic analysis of the
Hsp82/GRP94 chimeric enzymes [81,86]. Importantly, ATP hydrolysis
is essential for GRP94's activity in cells [108], at least with respect to
chaperoning insulin-like growth factors.8.4. Co-chaperones
A third potential difference with cytosolic HSP90s is the inter-
actions with co-chaperones. Many well-characterized molecules
serve as speciﬁc HSP90 co-chaperones, including HOP, p23, AHA1,
CDC37, FKBP-52 and UNC45, to facilitate client protein folding
[109,117,118]. These helper proteins clearly affect the conformation-
al equilibrium of Hsp90 and assist in the loading of client proteins
and in the regulation of the chaperone cycle. Unlike its cytosolic ho-
mologs, GRP94 has no known co-chaperones. These negative data in
combination with the alternative conformation seen in the crystal
structure may suggest a unique conformational and functional
cycle for GRP94. Alternatively, it is possible that interactions with
co-chaperones have not yet been deﬁned because techniques to un-
cover protein–protein interactions in the ER are not yet sophisticated
enough.
Recently CNPY3 (PRAT4A) has been shown to be necessary for
proper folding of Toll-like receptors [119,120] (Section 9.1).
CNPY3 has many characteristics of a GRP94 co-chaperone: it is
needed during TLR loading on GRP94; it interacts with GRP94 in
nucleotide-dependent manner; it is neither a chaperone for
GRP94, nor a client. Remarkably, unlike the co-chaperones that im-
pact the general action cycle of HSP90, CNPY3 is a client-speciﬁc
co-chaperone, involved in TLR but not integrin biogenesis
[119,120]. This ﬁnding suggests that the possibility that the confor-
mational state of GRP94 varies when it is engaged with different
clients, a possibility that is also consistent with the structural data
in Ref. [86]. It would be interesting to determine how CNPY3 im-
pacts the action cycle of GRP94, how it affects the ATPase activity
of GRP94 and how it modulates the client speciﬁcity or conforma-
tional state of the chaperone.
ASNA1 (TRC40/ARSA/GET3) is an ATPase required for the post-
translational delivery of tail-anchored (TA) proteins to the ER
[121]. At the same time, it was also discovered to be a necessary
factor for insulin secretion [122]. Recently, it was proposed that ac-
tivity of ASNA-1 is dependent on the presence of active GRP94 in
the cell, since simple overexpression of ASNA-1 does not restore in-
sulin secretion in GRP94 KO cells. In addition ASNA-1 has been
shown to be able to associate with GRP94 by yeast two-hybrid
and GST pull-down techniques (G. Kao, B. Natarajan, P. Naredi, Per-
sonal communication).
OS-9, a third co-factor of GRP94, is not client-speciﬁc, but rather
dedicated to a biological process: targeting misfolded proteins for
ER-associated degradation (Section 9.3). Its expression does not de-
pend on GRP94 activity and mutant GRP94 with or without ATPase
activity still bind to OS-9, unlike client proteins (Dersh and Argon
unpublished data). OS-9 has a mannose receptor homology domain
which endows it with carbohydrate-sensing capability [123]. OS-9 it-
self can distinguish between folded and misfolded conformations of
proteins, apparently using polypeptide-based cues to bind glycopro-
teins [124–126]. Thus, OS-9 may be a co-chaperone that directs the
activity of GRP94 towards quality control.
8.5. Activity in cells
The individual biochemical activities of GRP94 (ATP hydrolysis,
conformational changes, calcium and peptide binding) provide im-
portant molecular information, but to determine how they affect
the global in vivo activity of the chaperone, a cellular assay that de-
pends on chaperone activity of GRP94 toward IGF has been devel-
oped [16] (Section 9.1). As shown in Fig. 5, varying GRP94 mutants
have been tested and the ability to discriminate between wild type,
hypomorphic and inactive versions of the chaperone has been prov-
en. Existence of mutants that seems to have a modulatory impact on
the activity of GRP94 also raises the possibility that such an assay
could be used in testing the impact of posttranslational modiﬁcations
Fig. 5. An IGF-dependent cellular assay for the function of GRP94 variants. Differential
survival of grp94−/− cells in serum-free medium when transiently expressing GRP94-
GFP chimeric constructs. WT GRP94-GFP confers the highest survival. ΔK is an in-frame
deletion of amino acids 144–488 that is a chaperone-dead negative control. The point
mutant D128N is incapable of binding ATP [170] and Q427A is partially deﬁcient in
ATP hydrolysis in vitro[86]. This ﬁgure is adapted from Ref. [108].
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of site directed mutagenesis or naturally occurring ones and co-
chaperone binding (see Sections 6 and 8.4).
9. What does GRP94 do?
9.1. Chaperones protein folding
The most important activity of GRP94 is as a molecular chaperone
that directs folding and/or assembly of secreted and membrane pro-
teins. Unlike other ubiquitous luminal chaperones, however, GRP94
is a rather selective chaperone whose client list is much shorter
than that of other ubiquitously expressed ER chaperones, like BiP or
calreticulin. Many plasma membrane receptors and secreted prod-
ucts, like transferrin receptor and MHC class I proteins, do not require
GRP94's activity for proper folding and trafﬁc to the cell surface, as
demonstrated by knockout and knockdown cells (e.g. [15]). Those cli-
ents that are not only found in association with GRP94, but also re-
quire this association for proper expression are listed in Table 2.
Listed separately are examples of the many proteins for which there
is only association data with GRP94 without other criteria. This dis-
tinction is important, because association could arise simply becauseTable 2
Clients and putative substrates of GRP94.
Client protein Method Topology
MHC class II IPa, functionalb Membran
IgH IP, KOc, KDd Membran
IgL IP, KO, KD Soluble
BSDL (CEL) IP, functional Soluble
Toll-like Receptors KO, functional Membran
Integrins IP, KO, functional Membran
Platelet glycoprotein Ib–IX–V complex IP, KO, functional Membran
Thyroglobulin IP, functional Soluble
Insulin-like growth factor-I IP, KO, KD Soluble
Insulin-like growth factor-II IP, KO, KD Soluble
Apo B IP, pulse-chase
Collagen IP, functional Soluble
Clavata (plants) KO
p75 (Leishmania) IP, functional Membran
Others
Protein C IP Soluble
α1-antitrypsin (mutant) IP Soluble
Thrombospondin (TSP1) IP Soluble
HSV-1 glycoprotein B (mutant) IP Membran
a IP, immunoprecipitation.
b Functional, assembly or trafﬁc or activity of the protein ± GRP94.
c KO, knockout.
d KD, knockdown.GRP94 is an abundant luminal constituent and because it is known
to form complexes with many proteins, particularly when a mutation
causes accumulation in the ER lumen of such itinerant proteins. Thus,
a functional consequence of the association with the chaperone is an
important criterion.
The ﬁrst GRP94 clients discovered were from the immunoglobulin
(Ig) family: folding intermediates of either unassembled MHC class II
proteins [127] or Ig heavy or light chains [128], are complexed with
GRP94. GRP94 binds to L chain via their Ig-fold variable domains
and this feature also illustrates its relative selectivity, because BiP
binding peptides have been demonstrated in both the V and C do-
mains of this client [129,130]. The interaction with GRP94 is function-
ally important, because secretion of light chains is inhibited when
GRP94 is ablated [131]. On the other hand, Li et al. showed that
serum Ig levels are not depleted in mice whose GRP94 is deleted in
B cells [132], suggesting that there is a by-pass quality control mech-
anism that enables secretion without GRP94. However, GRP94 is im-
portant for lymphocyte development, as in its absence neither B nor
T cell lineages can progress beyond an early stage [133].
A second known client of GRP94 is BSDL. As discussed above
(Section 4), Lombardo et al. showed that BSDL is bound to GRP94
and other, unidentiﬁed proteins, and this complex is trafﬁcked to-
gether and is secreted from pancreatic cells [21,134].
Other clients of GRP94 are Toll-like receptors and integrins,
[15,135], which are oligomeric transmembrane proteins. Interesting-
ly, not all TLR or all integrins require chaperoning by GRP94: surface
expression of β1 integrins does not require GRP94, while others do
[136]. Among TLRs, both family members that are expressed on the
cell surface and those that are intracellular require GRP94's action
[135]. The deﬁciency in TLR expression leads to inefﬁcient innate im-
munity to select pathogens [15]. In neither the integrin nor the TLR
clients has the precise binding site for GRP94 been mapped. Drosoph-
ila gp93, when expressed in mammalian cells, can compensate for the
loss of mammalian GRP94 in supporting surface expression of several
integrins and TLRs [136]. Thus, as expected from the structural ho-
mology, there is considerable functional conservation among the
GRP94s during evolution. The remarkable insight derived from the
functional complementation of clients by orthologues is that despite
the evolutionary distance between Toll and mammalian TLRs (~15%
identity) or between ﬂy and mammalian integrins (~23% identity)
the GRP94s from either can chaperones these clients. There must,Size (kD) Binds to Reference
e ~28 K Unassembled [105]
e and soluble 50–80 V and C domains [106]




e 24 GPIX subunit [115]
660 Region I [154]
7.5 Mature domain [120,155]









782 M. Marzec et al. / Biochimica et Biophysica Acta 1823 (2012) 774–787therefore, be a common action cycle for GRP94 when it chaperones all
proteins, even though we know little of the details of such action
cycle.
The platelet glycoprotein Ib–IX–V complex is an oligomeric recep-
tor for von Willebrand factor and its absence leads to impairment of
platelets function. GRP94 binds selectively to the GPIX subunit and
not to the other two [137]. GRP94 is an obligate chaperone for this
glycoprotein complex and without it, there is no surface expression
and enhanced ERAD of the complex.
Thyroglobulin is a very large, multi-domain protein that binds
GRP94 as well as many other chaperones [138]. Region I of thyroglob-
ulin is a block of 1191 residues that is comprised of ~10 repeating,
disulﬁdes-rich units. Conformational maturation of region I is a limit-
ing step in thyroglobulin folding. This region contains binding sites
for both GRP94 and BiP [139]. Mutations causing hypothyroidism
are known to induce local/regional misfolding or to impede interac-
tions between protein domains that are required for thyroglobulin se-
cretion. Such mutants show higher avidity to GRP94 and to other
chaperones [140,141].
Among the known clients, insulin-like growth factors are distinct
both in their small size and their monomeric assembly state. Both
insulin-like growth factor-I and -II interact with GRP94 and in the ab-
sence of the chaperone do not mature and are not secreted [13,16]. It
is notable that IGF-I is N-glycosylated, while IGF-II is not, yet both de-
pend on GRP94 for their trafﬁc to the Golgi complex, where they are
processed proteolytically. Preliminary studies suggest that GRP94
binds to an epitope within the 67 amino acid secreted form of the
IGFs (unpublished data). GRP94 is an obligate chaperone for IGF bio-
synthesis and inhibition of GRP94 activity abrogates its secretion and
subsequent IGF receptor signaling. In this respect, the only other
known client that requires GRP94 stringently is the platelet glycopro-
tein complex, whereas most other client proteins (e.g. the Ig super-
family proteins) display a leakier, less stringent dependence on
GRP94. The requirement of IGF for GRP94 has profound physiological
consequences, since for example, mice whose GRP94 is depleted spe-
ciﬁcally in the musculature are considerably smaller and have lower
IGF levels [142].
Table 2 illustrates a major enigma of GRP94 - it is not clear what
features it could recognize in proteins, because apart from being
disulﬁde-bonded proteins, there is no obvious common denominator
among the listed clients. They represent different folds, from the Ig-
fold to the LRD fold, from all-beta sheet domains to helix-rich do-
mains, monomeric and oligomeric proteins and both single domain
and multi-domain clients.
The activity of chaperones in protein folding and in resolving protein
aggregation is often considered redundant or non-essential, partly be-
cause in many cases folding can proceed evenwithout chaperones alto-
gether, and partly because anti-aggregation activity can be performed
by multiple molecular chaperone without any obvious client protein
speciﬁcity. Furthermore, often there are homologous chaperones
in a given folding compartment (for example, yeast has 4 cytosolic
HSP70s; mammals have 2 cytosolic HSP90s). Nonetheless, inhibiting
or ablating chaperone activities by genetic means shows quite a differ-
ent picture: many chaperones are essential and provide unique, non-
overlapping functions in vivo, even if in vitro they are not essential.
Ablation of GRP94 can be accomplished either pharmacologically
or genetically. Many published studies employ the small molecule
inhibitors geldanamycin and radicicol (or their derivatives) to in-
hibit HSP90s and the processes that depend on them. It is impor-
tant to note that all current such inhibitors target GRP94 just as
efﬁciently as they do HSP90 and bind to the nucleotide-binding
site with similar afﬁnities [e.g. [81]]. Since the client spectra of
HSP90s and GRP94 are totally non-overlapping, the interpretation
of their effects is practically impossible. This point is particularly
relevant in the design and/or evaluation of HSP90 inhibitors in clin-
ical trials [143,144].9.2. Calcium binding
The activity of GRP94 as a luminal Ca++ binding protein has
long been appreciated [4,6]. Like the other abundant luminal pro-
teins, GRP94 is a low-afﬁnity, high-capacity calcium binding pro-
tein, that is estimated to have 15 calcium-binding sites, 4 with
moderate afﬁnity (KD~2 μM) and 11 with low afﬁnity
(KD~600 μM) [4]. Since there are no “EF hand” binding motifs in
the sequence, the Ca++ binding sites are likely to be clusters of
negatively charged residues. Several acidic regions are distributed
throughout the sequence of GRP94 and are distinct from the ho-
mologous regions in HSP90s (Fig. 2). One or two of the higher af-
ﬁnity Ca++ binding sites map to the charged linker domain that
follows the N-terminal ATPase domain [92]. Whether the Ca++
binding capacity of GRP94 is essential in vivo is not yet established
and it is possible that this function of GRP94 is redundant with
other proteins. For example, deletion of GRP94 in skeletal muscle
does not lead to an obvious defect in Ca++ homeostasis, presum-
ably because calsequenstrin-1 provides an even larger pool of
Ca++ binding in the sarcoplasmic reticulum, which is capable of
compensating for GRP94's loss [142]. Given the abundance of
calsequenstrin-1 in the sarcoplasmic reticulum of fast twitch mus-
cle ﬁbers [145,146] and given that each calsequestrin molecule
can bind twice the Ca++ ions as GRP94, calsequestrin has a much
higher Ca++ binding capacity and could mask the loss of GRP94
in this respect.
In addition to its apparent function as a calcium carrier, Ca++
binding regulates GRP94 activity. Free Ca++ at 100 nM, within the
physiologically relevant range, causes a conformational change, as
measured by decreased helical content of GRP94 [4]. Indications
that the charged linker itself undergoes conformational changes are
found by comparisons of the various crystal structures of GRP94,
but unfortunately, no speciﬁc structural information is available
about this domain. Ca++ binding at physiological concentrations
was shown to modulate the peptide-binding activity of GRP94 [92].
However, so far all the known functional and structural changes
only derive from in vitro experiments. Even though thapsigargin, an
inhibitor of the SERCA calcium pumps, induces the expression of
GRP94 in cells and tissues, there is yet no direct functional evidence
in vivo that calcium affects GRP94 activity.
9.3. Roles in quality control
Cells exercise control over the quality of secretory proteins both
by promoting their proper folding and by detection and disposal of
misfolded molecules. The disposal of proteins that misfold in the
lumen of the ER occurs by degradation by the proteasomes, thus
misfolded proteins have to be retro-translocated from the lumen to
the cytosol. Many components target misfolded proteins, remove
them from the ER, tag them with ubiquitin and direct them to pro-
teasomal degradation, and these components are known collectively
as the ER-associated degradation (ERAD) machinery. A major unre-
solved question of much current interest is the nature of the machin-
ery that triages misfolded from native proteins and selects the
former for translocation. More and more data point to a connection
between the folding machinery and the retro-translocation machin-
ery. Most directly, mutant α1-antitrypsin that is usually degraded
by ERAD is not degraded when GRP94 expression is ablated [124].
GRP94 cooperates with the lectin OS-9 (Section 8.4), which some-
how binds to GRP94 and delivers the mutant α1-antitrypsin to the
Hrd-1 ubiquitin ligase complex in the ER membrane. Both compo-
nents are needed for this delivery, as ablation of OS-9 also inhibits
degradation [124,125]. It is likely that other chaperones, like BiP/
GRP78, and other lectins, like XTP3 also mediate triaging of ERAD
substrates [147]. Furthermore, since ERAD of cholera toxin A1 subu-
nit does not involve binding of GRP94, but rather is sensitive to
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by all ERAD substrates and its selectivity will need to be elucidated
by future studies.
9.4. Peptide binding
There is ample literature about the peptide-binding activity of
GRP94 in the context of stimulating T cells to respond to foreign anti-
gens and enhance immunity. GRP94 has been independently identi-
ﬁed as gp96, a protein that serves as a potent stimulator of
antitumor activity [148] and later discovered to possess this immuno-
logical activity because it binds peptides, not because its own se-
quence is mutated in cancers [149]. This led to extensive
investigation of the role of GRP94 in “cross-priming” - the process
by which dendritic cells capture peptides derived from other cells
and then present them to, and activate naive CD8+ T cells ([150]
and reviewed in Refs. [151,152]). This pathway of peptide presenta-
tion is believed to play an important role in the generation of antiviral
and antitumor responses [151,152]). Most of the studies on cross-
priming via GRP94 use extracellular GRP94, either puriﬁed or recom-
binant protein, that is either loaded with a complex mixture of pep-
tides in the tissue of origin, or is deliberately loaded with the
desired antigenic peptide. Presentation of peptides via GRP94 is not
limited to viral peptides, and a number of cellular peptides, including
some derived from oncogenes have been shown to stimulate cellular
immunity effectively using this route. It is known that the GRP94-
peptide complex is taken up by dendritic cells and other ‘professional’
antigen presenting cells by a process of receptor-mediated endocyto-
sis, which relies on a number of scavenger receptors, including CD91
[153,154]. The peptide is separated from GRP94 and transferred on
MHC class I molecules [104,155], which then display it secondarily
on the cell surface, where it can be recognized by the T cell receptors
of the appropriate T cells. There is little doubt that in such scenario
potent activation of T cell immunity is possible and when optimized,
can be a powerful therapeutic tool [151]. Several molecular aspects of
the GRP94-dependent cross-priming process are still not clear, such
as why cross-priming is primarily an MHC class I / CD8+ T cell pro-
cess, even though the peptide-binding speciﬁcities of GRP94 and
MHC class I are quite different.
While immunization with GRP94-peptide complexes to achieve
cross-priming has been shown to be powerful in lab models as well
as in clinical trials, the physiological role of peptide presentation by
GRP94 has been controversial and recent studies argue against such
a physiological immune function. We have shown that a mutant
GRP94 with a deﬁcient peptide-binding capacity can still mediate
the chaperone function [108], thus uncoupling the two activities.
More directly, Yewdell et al. showed that cells whose expression of
GRP94 is silenced demonstrate no reduction in their abilities to
cross-prime antiviral CD8+ T cell responses in vivo[107].
9.5. Roles in ER stress
As discussed in Section 5, GRP94 and BiP/GRP78 are canonical
hallmarks of the UPR response, in both physiological and pathological
contexts. The similarity of their promoters explains at least in part
why these two, and other ER stress genes are co-induced. As noted
above, GRP94 and BiP are co-induced also by physiological ER stress,
for example during differentiation of hepatocytes, acinar cells or B
cells [38–43]. Signals that induce such differentiation into profession-
al secretory cells rely on the same signal transduction machinery as
the stress responses, and this usage of ER stress signaling in differen-
tiation makes physiological sense, because the major object of such
differentiation program is to up-regulate the secretory machinery, in-
cluding the ER protein folding machinery.
GRP94 is connected to ER stress responses also through its
chaperoning of clients, for example insulin-like growth factors (IGFs).LikeGRP94 itself, mammalian IGF-I and -II are targets of the ER stress re-
sponse at the transcriptional level [156]. The up-regulation of GRP94
levels during the UPR augments the increased transcription by promot-
ing the folding of signaling-competent IGF-I and -II [16]. Together, the
two effects lead to increased hormone production under stress condi-
tions enables cells to initiate the IGF signaling pathway, which is used
to cope with metabolic stresses. Furthermore, administration of IGF-I
together with other inducers of ER stress signiﬁcantly potentiates the
UPR, likely boosting the folding capacity of the compartment, as needed
to alleviate the initial stress signal [157]. The cellular outcome of this
two-way relationship is promotion of recovery from stress, augmenta-
tion of nutrient sensing and protein translation mechanisms and sup-
pression of apoptosis [158,159].
GRP94 (as well as some other ER resident proteins) is often found
in multiple tumors as a highly over-expressed protein and many pub-
lications imply it as a candidate marker for monitoring tumor pro-
gression [160,161]. This line of work points to the exciting relation
between ER stress and cancer, a relation whose underlying mecha-
nisms should be investigated further.
9.6. Interactions with other ER chaperones
Both protein folding and quality control require coordinate activi-
ty of many ER components. The folding of many secretory proteins,
particularly the multi-domain oligomeric ones, requires more than
one chaperone, presumably because there are multiple bottlenecks
in each folding pathway. Because different chaperones recognize
their clients based on distinct structural features (e.g. linear peptides,
carbohydrates, disulﬁde bonds), they often work either in parallel or
in sequence through the assembly of transient complexes [162,163].
GRP94 and BiP are often reported to associate with secretory proteins
(e.g. [138]) and sometimes at a consistent stoichiometry, implying
such transient complexes. During the folding of Ig, GRP94 and BiP
work sequentially, with BiP binding preferentially to earlier folding
intermediates and GRP94 - to later intermediates. The two chaper-
ones also form a ternary complex with the folding client, presumably
to transfer it from BiP to GRP94 [128,164]. This sequence of interac-
tion ﬁts well with the broad peptide speciﬁcity of BiP and the more
selective recognition by GRP94. Apparently, GRP94 does not always
work in concert with BiP, since GRP94 association is detected during
the biosynthesis of IGF without a corresponding interaction with
BiP. Interestingly, GRP94 has not been reported to act in concert
with calnexin or calreticulin, suggesting that there is functional sepa-
ration between sets of chaperones, perhaps based on the rules pro-
posed by Molinari [165].
The coordination of ER folding factors is most apparent in the mas-
sive UPR transcriptional activation, where expression of components
of the protein folding and degradation machinery is coordinately
up-regulated. Such orchestrated activation was ﬁrst discovered by
Lee et al., using pharmacological treatments as UPR inducers
[46,166,167], and then shown to be relevant for physiological pro-
cesses, such as terminal plasma cell differentiation [38,40]. The coor-
dinate transcriptional regulation of GRP94, BiP, PDI and other
components of the machinery, together with their biochemical func-
tions suggest that they form a functional network that both increases
the efﬁciency of folding and reduces the chances of misfolded pro-
teins escaping. Such an ER network would be equivalent to the cyto-
solic folding factors that are known to work in concert by forming
dynamic complexes [162,163].
One prediction of the putative quality control network is that de-
pletion of one chaperone would affect either the activity or the level
of expression of another. Indeed, several studies address this predic-
tion. In C. elegans, there is compensatory and mutual regulation
among nine ER chaperones, including BiP (hsp4) and GRP94
(T05E11.3) [54]). Suppression of GRP94 by RNAi activates the IRE-1/
XBP-1 branch of the UPR and induces BiP expression. BiP is also
784 M. Marzec et al. / Biochimica et Biophysica Acta 1823 (2012) 774–787induced when C. elegans E3 ubiquitin ligase HRD-1 is silenced [168],
showing that components of the ERAD pathway are integral parts of
the quality control network. Such compensatory relationship extends
to mammalian cells: knockdown or inactivation of BiP induces the ex-
pression of GRP94, PDI, calreticulin and ERp57, and silencing of calre-
ticulin stimulates the expression of GRP94 and PDI [169]. Calreticulin-
null embryonic ﬁbroblasts also show constitutively higher level of
GRP94 and other ER proteins (Eletto and Argon, unpublished). On
the other hand, this phenomenon is not universal: GRP94-null cells
do not display increased expression of other chaperones [13]. Thus,
there is conserved regulatory relationship, whereby the loss of some
quality control components leads to compensatory up-regulation of
others, but the effects are not always mutual.
10. Conclusions
GRP94 has long been among the more enigmatic chaperones.
Despite many similarities to HSP90, not long ago it was still not
known whether it is an ATPase, how it binds clients and whether
it has co-chaperones. In addition, since it is not necessary for the
function of yeast ER, it was not clear what important functions
lead to its ubiquitous expression, abundance and sequence conser-
vation. Much progress in recent years has started uncovering parts
of the mystery. The expansion of the known client spectrum shows
that GRP94 is a general chaperone. The abilities to knockout and knock-
down its expression have uncovered clients for which GRP94 interac-
tion is obligatory and shown that it is an essential chaperone in the
development of metazoans as well as for the functions of several cell
types and tissues. The development of cell-based assays (Fig. 5) has
started to reveal the critical molecular activities of the protein, enabled
teasing them apart and relating the in vitro activities of GRP94 domains
to its overall in vivo actions. These advances revealed that GRP94 acts
more similarly to HSP90 than had been thought previously, and the dis-
covery of the ﬁrst co-chaperones, albeit different types of factors than
those found in the cytosol, suggests that the proteome associated with
GRP94 may soon be characterized. Some of the important remaining
challenges are to identify the client binding site of the chaperone, deter-
mine how it affects the folding process and elucidate how the ER varia-
tions on the HSP90 action cycle lead to recognition, binding and release
of client proteins.
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